SCHEMBL7003240

SCHEMBL7003240

O=C1CCN2CCC[C@@H]2C1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.43
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
L3MBTL3 Q96JM7 4/20 0.36
L3MBTL1 Q9Y468 4/20 0.36
CHRNA7 P36544 1/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
TP53BP1 Q12888 1/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
SRD5A2 P31213 1/20 0.33
MPO P05164 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRL1 P41146 1/20 0.33
HTR6 P50406 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL94206 1.00 MAPK1 (0.43) MAPK1KDM4EALDH1A1L3MBTL3L3MBTL1
SCHEMBL5250892 1.00 MAPK1 (0.43) MAPK1KDM4EALDH1A1L3MBTL3L3MBTL1
SCHEMBL132894 0.94 MAPK1 (0.42) MAPK1L3MBTL3L3MBTL1TP53BP1SRD5A2
SCHEMBL863778 0.91 MAPK1 (0.43) MAPK1KDM4EALDH1A1L3MBTL3L3MBTL1
SCHEMBL11008209 0.87 MAPK1 (0.43) MAPK1KDM4EALDH1A1L3MBTL3L3MBTL1
SCHEMBL11003669 0.85 MAPK1 (0.42) MAPK1L3MBTL3L3MBTL1OPRM1OPRL1
SCHEMBL863645 0.85 MAPK1 (0.42) MAPK1L3MBTL3L3MBTL1TP53BP1OPRM1
SCHEMBL8149056 0.85 MAPK1 (0.33) MAPK1KDM4EALDH1A1L3MBTL3L3MBTL1
SCHEMBL1822607 0.84 MAPK1 (0.45) MAPK1ALDH1A1L3MBTL3L3MBTL1CTDSP1
SCHEMBL30761740 0.83 MAPK1 (0.41) MAPK1ALDH1A1L3MBTL3L3MBTL1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007063418-A2 SUBSTITUTED INDOLE COMPOUNDS HAVING NOS INHIBITORY ACTIVITY NEURAXON, INC. (CA) 2007-06-07 WO disclosed
US-6562809-B1 Contraction of coronary arteries may be mediated by its stimulation of the 5-HT1B (formerly 5-HT1D beta); compounds selective for a 5-HT1D receptor NPS ALLELIX CORP. (CA) 2003-05-13 US disclosed
EP-1114049-B1 3-BICYCLOINDOLE COMPOUNDS AS 5-HT1D RECEPTOR LIGANDS NPS ALLELIX CORP (CA) 2003-03-19 EP disclosed
EP-1114049-A1 3-BICYCLOINDOLE COMPOUNDS AS 5-HT1D RECEPTOR LIGANDS NPS Allelix Corp. (CA) 2001-07-11 EP disclosed
WO-2000017198-A1 3-BICYCLOINDOLE COMPOUNDS AS 5-HT1D LIGANDS ALLELIX BIOPHARMACEUTICALS INC. (CA) 2000-03-30 WO disclosed